The testing facility, located on the curbside of Level 4 at Terminal 2 for departing passengers, is also available for non-passengers visiting the airport to drop off or receive their loved ones, it added.
The city airport on Saturday said it has extended the availability of its express coronavirus infection test facility also to departing passengers and non-passengers. The RT-PCR test facility is functional from October 15, the airport said in a release.
Initially launched for arriving international transit passengers in line with the Civil Aviation Ministry's directives, the Chhatrapati Shivaji Maharaj International Airport (CSMIA) has now further extended the availability of the test facility for passengers departing from the airport as well, the airport operator said in a release. The testing facility, located on the curbside of Level 4 at Terminal 2 for departing passengers, is also available for non-passengers visiting the airport to drop off or receive their loved ones, it added.
The initiative addresses passenger concerns regarding the different COVID-19 regulations across domestic and international destinations, it said adding, departing passengers can undergo the test at CSMIA before travelling to their onward destination and produce their negative test report to skip institutional quarantine at their destination. The Mumbai airport had first launched the RT-PCR test facility last month for arriving international passengers transiting to a domestic destination from Mumbai as a measure to skip institutional quarantine upon arrival.
This was later extended to all passengers arriving at the airport as directed by the MoCA. Since the commemoration of the test facility on September 6, the airport has witnessed a total of over 3,340 passengers opting for the test, with an average 100 test per day being conducted, said the release.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
Till date 38 passengers tested positive, of the total tests conducted at the airport facility so far and they were transferred by the state authorities to designated COVID-19 institutions, according to the airport operator. Departing passengers can make an online booking through the test feature available on the CSMI airport website or register themselves at the helpdesk set up at departures to enrol for the RT-PCR test before entering the terminal and receive a digital copy mailed directly or can also collect the physical copy of the test report within eight hours, it stated.Passengers departing from the airport are encouraged to arrive at the terminal 8-12 hours before their scheduled departure, it added.